EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma‐based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India – Diagnostic assessment of dementia

Rashmita Pradhan, Masroor Anwar, Abhijith R Rao, Ashish Datt Upadhyay, Abhishek Gupta, Abhinay Kumar Singh, Aparajit Ballav Dey, Sharmistha Dey

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Rashmita Pradhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Dementia, Cognitive Dysfunction, Aging. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: US National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Major neurocognitive disorder (MNCD) represents a critical public health crisis. From the two waves of the Longitudinal Aging Study in India‐Diagnostic Assessment of Dementia, we investigated the predictive power of longitudinal alterations in plasma proteins to predict the progression from mild cognitive impairment (MCI) to MNCD in India. METHODS This prospective cohort followed 4635 participants over 55 months. Plasma levels of amyloid beta (Aβ) 42/Aβ40 ratio, neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau phosphorylated at threonine 181 (pTau181), and total tau (t‐tau) were measured via single molecule array technology. Comprehensive geriatric assessments were conducted, and Clinical Dementia Rating (CDR) scores were measured. RESULTS As participants progressed from MCI to MNCD, significant declines in cognitive and functional parameters coincided with elevated plasma protein levels. Biomarkers (GFAP, NfL t‐tau, and pTau181) demonstrated strong predictive accuracy, with area under the curve values of 81%, 71%, 74%, and 67%, respectively. DISCUSSION Plasma biomarkers effectively estimate dementia progression rates. These findings support using blood‐based markers to monitor and track disease trajectory in the Indian population, offering significant clinical utility for early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaCognitive DysfunctionAgingHumansDisease ProgressionIndiaMaleBiomarkersFemaleLongitudinal Studiestau ProteinsAgedAmyloid beta-PeptidesNeurofilament ProteinsProspective StudiesGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

Simoalongitudinal studymajor neurocognitive disorder (MNCD)mild cognitive impairment (MCI)plasma protein markers

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesNeurofilament ProteinsGlial Fibrillary Acidic Proteinneurofilament protein L

Autor:innen und Institutionen

  • Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.

Förderung

  • US National Institute on Aging

Zitieren

APA

Pradhan, R., Anwar, M., Rao, A. R., Upadhyay, A. D., Gupta, A., Singh, A. K., Dey, A. B., & Dey, S. (2026). Plasma‐based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India – Diagnostic assessment of dementia. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71650

Vancouver

Pradhan R, Anwar M, Rao AR, Upadhyay AD, Gupta A, Singh AK, et al. Plasma‐based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India – Diagnostic assessment of dementia. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71650

BibTeX
@article{Pradhan2026,
  author = {Pradhan, Rashmita and Anwar, Masroor and Rao, Abhijith R and Upadhyay, Ashish Datt and Gupta, Abhishek and Singh, Abhinay Kumar and Dey, Aparajit Ballav and Dey, Sharmistha},
  title = {Plasma‐based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India – Diagnostic assessment of dementia},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71650}
}
Kostenlos starten →